Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroo Hoshino is active.

Publication


Featured researches published by Hiroo Hoshino.


Antimicrobial Agents and Chemotherapy | 1989

Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compounds.

Jun-Ichi Seki; N Shimada; K Takahashi; T Takita; Tomio Takeuchi; Hiroo Hoshino

Oxetanocin is a novel nucleoside containing a 4-membered sugar, oxetanosyl-N-glycoside, and adenine. The effects of oxetanocin and related compounds on the infectivity of human immunodeficiency virus (HIV) were examined. They inhibited HIV infectivity in vitro. Allopurinol and mycophenolic acid produced additive anti-HIV effects when added with these compounds. Images


Biochemical and Biophysical Research Communications | 1991

Inhibition of infection with human immunodeficiency virus type 1 by sulfated gangliosides

Atsushi Handa; Hiroo Hoshino; Katsuyuki Nakajima; Masakazu Adachi; Kiyoshi Ikeda; Kazuo Achiwa; Takeshi Itoh; Yasuo Suzuki

Four kinds of gangliosides, namely GM1a, GD1a, GD1b and GT1b and their sulfated derivatives were examined for antiviral activities against human immunodeficiency virus type 1 and abilities to modulate CD4 antigen on the cell surface. The infection of human T cells with the virus was markedly inhibited by treatment with the sulfated gangliosides at a concentration of 10 micrograms/ml, while the non-sulfated gangliosides had only weak antiviral activities. The sulfated gangliosides completely inhibited syncytium formation induced by HIV-1 at 30 micrograms/ml. The CD4 antigen on the surface of T cells became hardly detectable after treatment with them. They did not damage cells, nor prolong the activated partial thromboplastin time at concentrations of up to 100 micrograms/ml, suggesting that they may have little side effect in vivo.


Journal of Molecular Evolution | 1992

Six strains of human immunodeficiency virus type 1 isolated in Japan and their molecular phylogeny

Nobuaki Shimizu; Yashuhiro Takeuchi; Takuji Naruse; Minoru Inagaki; Etsuko N. Moriyama; Takashi Gojobori; Hiroo Hoshino

SummaryFive strains of human immunodeficiency virus type 1 (HIV-1) were isolated from five Japanese hemophilia patients. Two isolates, HIV1[GUN-1] and HIV-1[GUN-2], were from brother patients with hemophilia B and the other three isolates, HIV-I[GUN-3], HIV-1[GUN-4], and HIV1[GUN-5], were from hemophilia A patients. Another HIV-1 strain, HIV-1[GUN-6], was isolated from a Canadian male homosexual with AIDS. The restriction endonuclease cleavage maps of the proviral genomes of these six HIV-1 strains revealed that they were apparently different from each other. The phylogenetic trees constructed using restriction maps and nucleotide sequences were quite similar, indicating that phylogenetic analyses of Japanese HIV-1 isolates can be done using restriction maps of the proviruses. Phylogenetic analyses showed that they were more closely related to HIV-1s which had been reported to be isolated from homosexual patients in the United States than those isolated from African patients. In particular, GUN-1 and GUN-2 isolates were on the branch of a San Francisco isolate, ARV2, while GUN-5 and GUN-6 isolates were on the branch of HTLV-IIIB-related isolates.


FEBS Letters | 1989

Patterns of nucleotide substitutions and implications for the immunological diversity of human immunodeficiency virus

Nobuaki Shimizu; Takashi Okamoto; Etsuko N. Moriyama; Yasuhiro Takeuchi; Takashi Gojobori; Hiroo Hoshino

Human immunodeficiency virus (HIV) exhibits immunological hypervariability, which has been an obstacle to successful production of effective anti‐HIV vaccines. In this study, we estimated patterns of nucleotide and amino acid substitutions in the env gene of HIVs, with the aim of finding characteristics of the mechanism which generates the immunological diversity of the env protein of HIVs. We found that nucleotide changes between A and G are predominant compared to those between other nucleotides. Since this feature is consistent with the pattern of nucleotide substitutions of other retroviral genes but is quite different from those of most eukaryotic genes, a high rate of nucleotide substitution between A and G appears to be specific for retroviruses including HIVs. We discuss the biological relationship between this biased substitution and the mechanism generating hypervariability of epitopes on the env protein of HIVs.


Microbiology and Immunology | 1991

Human Immunodeficiency Virus Infection in Cells of Myeloid‐Monocytic Lineage

Hiroshi Ushijima; Masatake Dairaku; Hitoshi Honma; Koushi Yamaguchi; Hiroyuki Shimizu; Hideaki Tsuchie; Kenji Abe; Akiko Yamamoto; Hiroo Hoshino; Werner E. G. Müller

We established persistent infection with a strain of human immunodeficiency virus type I, HTLV‐IIIB, in a promyelomonocytic cell line, ML‐1 (CD4 antigen nearly negative and CD4 mRNA negative), and a promonocytic cell line, THP‐1 (CD4 antigen positive). Different reaction of giant cell formation was found after co‐cultivation of infected and uninfected cells of ML‐1, HL‐60, THP‐1 and U‐937 cell lines with uninfected and infected MOLT4 (a T‐lymphoma cell line).


Journal of Virology | 1991

Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.

Yasuhiro Takeuchi; M Akutsu; K Murayama; Nobuaki Shimizu; Hiroo Hoshino


Journal of Neurosurgery | 1990

Enhanced expression of the sis and c-myc oncogenes in human meningiomas

Kiyoshi Kazumoto; Masaru Tamura; Hiroo Hoshino; Yasuhito Yuasa


The Journal of Antibiotics | 1991

ANTIFUNGAL AND ANTIVIRAL ACTIVITIES OF BENANOMICINS AND THEIR ANALOGUES

Shinichi Kondo; Shuichi Ivy Heights Gomi; Daishiro Ikeda; Masa Hamada; Tomio Takeuchi; Hideaki Iwai; Jun-Ichi Seki; Hiroo Hoshino


Japanese Journal of Cancer Research | 1992

Inhibition of Heat Inactivation of Reverse Transcriptase of Human Immunodeficiency Virus Type 1 by Seropositive Sera

Toshiyuki Nagumo; Yasuhiro Takeuchi; Hiroo Hoshino


Journal of Cancer Research and Clinical Oncology | 1989

Frequent lack of antibodies against human T-cell leukemia virus type I gag proteins p24 or p19 in sera of patients with adult T-cell leukemia.

Noriyuki Suetake; Yasuhiro Takeuchi; Nobuaki Shimizu; Hiroshi Uesato; Takayoshi Kuroume; Hiroo Hoshino

Collaboration


Dive into the Hiroo Hoshino's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasuhito Yuasa

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Etsuko N. Moriyama

National Institute of Genetics

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge